ADMINISTRATION The Office of Translational Research (OTR), under the leadership of CCSG deputy director Dr. Robert Bast, coordinates and implements all administrative functions related to the CCSG. Dr. Bast has a dual reporting relationship, reporting directly to Dr. Giulio Draetta, chief scientific officer, and to Dr. Peter Pisters, MD Anderson president and CCSG PI for matters relating to the CCSG. Dr. Bast's staff provides administrative support and financial, scientific, and technical oversight for the CCSG programs; for all institutional shared resources, including CCSG core facilities; and for all other CCSG components, including Clinical Protocol and Data Management (CPDM), the Protocol Review and Monitoring System (PRMS), Community Outreach and Engagement, Career Enhancement and Related Activities, Development Funds, Senior Leadership, Planning and Evaluation, and CCSG administrative supplements. OTR staff serve on many of MD Anderson's advisory and oversight committees, including MD Anderson's Moon Shot Operations and Executive Committee and committees responsible for capital equipment allocation, oversight of research data storage, and financial controls. Administrative support is provided in the following areas: 1) business operations and financial management of shared resources; 2) central organization and coordination for the scientific and technical aspects of shared resource operations; 3) facilitation of programmatic interactions and engagement; 4) facilitation of communication between center director, program leaders, shared resource directors, and program members; 5) development, management, and maintenance of databases for program funding, program membership, program member publications, program member biographical information, and shared resource utilization; 6) allocation and monitoring of the use of CCSG development funds; 7) coordination and writing of CCSG progress reports and competitive renewal applications; and 8) organization of CCSG Executive Committee and annual External Advisory Board meetings.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016672-44
Application #
9997791
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
44
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Ma, Grace X; Lee, Minsun M; Tan, Yin et al. (2018) Efficacy of a community-based participatory and multilevel intervention to enhance hepatitis B virus screening and vaccination in underserved Korean Americans. Cancer 124:973-982
Peng, Guang; Mills, Gordon B (2018) Surviving Ovarian Cancer: An Affair between Defective DNA Repair and RB1. Clin Cancer Res 24:508-510
Radovich, Milan; Pickering, Curtis R; Felau, Ina et al. (2018) The Integrated Genomic Landscape of Thymic Epithelial Tumors. Cancer Cell 33:244-258.e10
Tetzlaff, Michael T; Nelson, Kelly C; Diab, Adi et al. (2018) Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients. J Immunother Cancer 6:14
Tayob, Nabihah; Richardson, Peter; White, Donna L et al. (2018) Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System. BMC Med Res Methodol 18:1
Caruso, Joseph A; Duong, Mylinh T; Carey, Jason P W et al. (2018) Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies. Cancer Res 78:5481-5491
Yu, Wangie; Chen, Yunyun; Dubrulle, Julien et al. (2018) Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism. Sci Rep 8:4306
Tanco, Kimberson; Azhar, Ahsan; Rhondali, Wadih et al. (2018) The Effect of Message Content and Clinical Outcome on Patients' Perception of Physician Compassion: A Randomized Controlled Trial. Oncologist 23:375-382
Elimova, Elena; Wang, Xuemei; Qiao, Wei et al. (2018) Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large Cohort. Oncology 94:345-353
Hoadley, Katherine A; Yau, Christina; Hinoue, Toshinori et al. (2018) Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Cell 173:291-304.e6

Showing the most recent 10 out of 12418 publications